TY - JOUR
T1 - Defining early seizure outcomes in pediatric epilepsy
T2 - The good, the bad and the in-between
AU - Berg, Anne T.
AU - Shinnar, Shlomo
AU - Levy, Susan R.
AU - Testa, Francine M.
AU - Smith-Rapaport, Susan
AU - Beckerman, Barbara
AU - Ebrahimi, Nader
N1 - Funding Information:
We are especially grateful to the physicians in Connecticut who have referred their patients to this study, Drs. Francis Dimario, Robert Cerciello, Barry Russman, Michelle Kleiman, Carol Leicher, Edwin Zalneraitis, Philip Brunquell, Laura Ment, Edward Novotny, Bennet Shaywitz, S. Nallainathan, Alok Bhargava, Martin Kreminitzer, Barbara Coughlin, Harriet Fellows, Jack Finkelstein, Daniel Moalli, Louise Resor, Owen Erlich, Bernard Giserman, John Monroe, Lawrence Rifkin, and Murray Engel. Dr. Eugene Shapiro has kindly facilitated many administrative issues for us. We also thank Wuthikrai Uayingsak for his exceptional programming expertise. This study would not be possible without the generous participation of the many parents and their children. This study was funded by a grant from the National Institutes of Health-NINDS RO1 NS31146.
PY - 2001
Y1 - 2001
N2 - Purpose: To examine different approaches to classifying seizure outcomes. Methods: In a prospective cohort study of children (N=613) with newly diagnosed epilepsy, seizure outcomes at 2 years were classified as 'good' (≥1 year remission), 'bad' or 'intractable' (≥2 AED failures, ≥1 seizure/month over ≥18 months), and 'indeterminate' (neither 'good' nor 'bad'). Outcomes at 2 years were compared to outcomes in those followed 4 or more years. The associations of three commonly studied prognostic factors, etiology, age at onset, and syndromic grouping with the three-level outcome were assessed. Results: 595 (97.1%) children were followed ≥2 years. A 'good', indeterminate, and 'bad' outcome was present in 314 (52.8%), 235 (38.3%), and 46 (7.7%) children. Problems with treatment were recorded in 64.7% of the indeterminate group. In 390 children followed ≥4 years, early 'good' and 'bad' outcomes persisted in ∼80%. About half of those with indeterminate 2-year outcomes later achieved remission, 8% met criteria for intractability, and 37% remained indeterminate. Most of the associations with etiology, age, and syndrome were due to variation in the proportion that met criteria for intractability and not remission. Conclusions: Many children have indeterminate outcomes, often in association with treatment issues. Clearly 'good' and 'bad' early outcomes can be identified and persist ≥2 years later. In the absence of pharmaco-resistance, lack of early remission (indeterminate outcome) is usually not associated with a bad outcome, at least over the next few years.
AB - Purpose: To examine different approaches to classifying seizure outcomes. Methods: In a prospective cohort study of children (N=613) with newly diagnosed epilepsy, seizure outcomes at 2 years were classified as 'good' (≥1 year remission), 'bad' or 'intractable' (≥2 AED failures, ≥1 seizure/month over ≥18 months), and 'indeterminate' (neither 'good' nor 'bad'). Outcomes at 2 years were compared to outcomes in those followed 4 or more years. The associations of three commonly studied prognostic factors, etiology, age at onset, and syndromic grouping with the three-level outcome were assessed. Results: 595 (97.1%) children were followed ≥2 years. A 'good', indeterminate, and 'bad' outcome was present in 314 (52.8%), 235 (38.3%), and 46 (7.7%) children. Problems with treatment were recorded in 64.7% of the indeterminate group. In 390 children followed ≥4 years, early 'good' and 'bad' outcomes persisted in ∼80%. About half of those with indeterminate 2-year outcomes later achieved remission, 8% met criteria for intractability, and 37% remained indeterminate. Most of the associations with etiology, age, and syndrome were due to variation in the proportion that met criteria for intractability and not remission. Conclusions: Many children have indeterminate outcomes, often in association with treatment issues. Clearly 'good' and 'bad' early outcomes can be identified and persist ≥2 years later. In the absence of pharmaco-resistance, lack of early remission (indeterminate outcome) is usually not associated with a bad outcome, at least over the next few years.
KW - Intractable epilepsy
KW - Predittion
KW - Prognosis
KW - Remission
KW - Seizure outcomes
UR - http://www.scopus.com/inward/record.url?scp=0035203834&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0035203834&partnerID=8YFLogxK
U2 - 10.1016/S0920-1211(00)00184-4
DO - 10.1016/S0920-1211(00)00184-4
M3 - Article
C2 - 11137389
AN - SCOPUS:0035203834
SN - 0920-1211
VL - 43
SP - 75
EP - 84
JO - Epilepsy Research
JF - Epilepsy Research
IS - 1
ER -